Detailed View
SGMT - Sagimet Biosciences Inc. - Seri
Latest filing: 2026-06-30 | Reporting: gaap
Market Cap
650,179,520
Adj EBIT (TTM)
-44,478,000
Enterprise Value
410,051,520
Last Price
10.46
Earnings Yield
-10.85%
Return on Capital
-17.24%
Capital
258,011,000
1Y Price Chart
Last Price: -
1Y Change: -
Company Summary
Loading summary...
| endDate | formType | fiscalYear | Revenue | OperatingIncomeLoss |
|---|---|---|---|---|
| 2026-06-30 | 10-Q | 2026 | 0 | -27,531,000 |
| 2026-03-31 | 10-Q | 2026 | 0 | -11,713,000 |
| 2025-12-31 | 10-K (Q4 derived) | 2025 | 0 | 40,890,000 |
| 2025-09-30 | 10-Q | 2025 | 0 | -46,124,000 |
| 2025-06-30 | 10-Q | 2025 | 0 | -31,790,000 |
| 2025-03-31 | 10-Q | 2025 | 0 | -19,865,000 |
| 2024-12-31 | 10-K (Q4 derived) | 2024 | 0 | 9,930,000 |
| 2024-09-30 | 10-Q | 2024 | 2,000,000 | -36,259,000 |
Notice something wrong?
Submit a quick report with a snapshot of the values you are seeing.